ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Internal Medicine

Top Internal Medicine Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
GEORGE SCHARYJ M.D.

Internal Medicine

6,288

$350K

202
152 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

23%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $56

PHILLIP POULOS M.D.

Internal Medicine

16,571

$3.29M

782
331 are 65+

1%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

34%
prescriptions for brand name drugs

Avg: 26%

$198
Average prescription price

Avg: $56

MILTON BYRD MD

Internal Medicine

7,581

$351K

316
272 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

ADEWUNMI SOBOWALE D.O,

Internal Medicine

9,369

$529K

268
176 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

19%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$56
Average prescription price

Avg: $56

RAM PURI M.D.

Internal Medicine

18,388

$827K

503
369 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 26%

$45
Average prescription price

Avg: $56

DEVELL YOUNG M.D.

Internal Medicine

16,177

$777K

485
367 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$48
Average prescription price

Avg: $56

HARVEY SANDERS M.D.

Internal Medicine

13,380

$489K

605
421 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

OLADAPO FAWIBE MD

Internal Medicine

20,985

$927K

615
318 are 65+

36%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

RASHMI HOODA MD

Internal Medicine

8,192

$449K

310
117 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

40%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

WILLIAM RAWLINGS M.D.

Internal Medicine

4,593

$212K

186
159 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

VIJITHA PRASAD M.D.

Internal Medicine

21,753

$994K

663
516 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$46
Average prescription price

Avg: $56

JOHN DEMICCO M.D.

Internal Medicine

12,091

$1.14M

437
270 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

31%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$94
Average prescription price

Avg: $56

SAMRAJYA GOGINENI M.D.

Internal Medicine

3,818

$187K

158
95 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$49
Average prescription price

Avg: $56

WILLIAM LAWS MD

Internal Medicine

14,850

$542K

558
508 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 26%

$36
Average prescription price

Avg: $56

JAMES METTS MD

Internal Medicine

9,997

$276K

630
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$28
Average prescription price

Avg: $56

LUTHER THOMAS M.D.

Internal Medicine

16,284

$879K

479
393 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 26%

$54
Average prescription price

Avg: $56

EDET BASSEY MD

Internal Medicine

12,551

$504K

368
188 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

28%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$40
Average prescription price

Avg: $56

THOMAS FERRARI M.D.

Internal Medicine

29,126

$1.65M

1018
546 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

25%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

NEIL GORDON M.D.

Internal Medicine

18,628

$687K

502
408 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

38%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

15%
prescriptions for brand name drugs

Avg: 26%

$37
Average prescription price

Avg: $56

MOHAMMAD KHAN M.D

Internal Medicine

23,449

$1.33M

593
340 are 65+

13%
patients receiving schedule two controlled substances

Avg: 3%

39%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 26%

$57
Average prescription price

Avg: $56

JIMMIE WILLIAMS MD

Internal Medicine

5,742

$179K

287
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 26%

$31
Average prescription price

Avg: $56

CHARLES GEBHARDT M.D.

Internal Medicine

9,484

$519K

353
265 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 26%

$55
Average prescription price

Avg: $56

ANDREW DEKLE MD

Internal Medicine

21,639

$891K

917
590 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

32%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 26%

$41
Average prescription price

Avg: $56

ALLYN JOHNSON MD

Internal Medicine

4,998

$221K

115
85 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

52%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 26%

$44
Average prescription price

Avg: $56

MUKESH AGARWAL M.D.

Internal Medicine

12,569

$472K

531
326 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

18%
patients receiving schedule three controlled substances

Avg: 11%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 26%

$38
Average prescription price

Avg: $56

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank